Diabetes Mellitus, particularly Type-2 Diabetes (T2DM), is traditionally described as a disorder of elevated blood glucose. However, emerging evidence suggests that hyperglycemia is a downstream manifestation rather than the primary cause. This paper proposes that T2DM is fundamentally a metabolic–inflammatory disorder characterized by insulin resistance, chronic low-grade inflammation, and energy mismanagement at the cellular level. Pancreatic β-cell dysfunction is shown to be largely secondary to prolonged metabolic overload. The paper also distinguishes autoimmune diabetes from metabolic diabetes and outlines non-pharmacological, evidence-based strategies for metabolic restoration. This perspective further explores diabetes as a systemic metabolic– inflammatory disorder involving impaired cellular energy regulation and disrupted microbial– cellular interactions, extending beyond a purely insulin-centered framework.
Sumeru Ray (Sun,) studied this question.